EPIZYME, INC. Patent Applications Rejected
158 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-01-15: Application 19022493; Invention SUBSTITUTED INDOLES AND METHODS OF USE THEREOF; Applicant Epizyme, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2024-06-28: Application 18757878; Invention SUBSTITUTED INDOLES AND METHODS OF USE THEREOF; Applicant Epizyme, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2024-06-14: Application 18743249; Invention PRMT5 INHIBITORS AND USES THEREOF; Applicant Epizyme, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2024-04-11: Application 18632510; Invention METHODS OF TREATING WHSC1-OVEREXPRESSING CANCERS BY INHIBITING SETD2; Applicant Epizyme, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2025-01-15 | 19022493 | SUBSTITUTED INDOLES AND METHODS OF USE THEREOF | Epizyme, Inc. | Abandoned -- Incomplete Application (Pre-examination) | John Lampe John Campbell Kenneth Duncan Megan Alene Cloonan Foley Darren Martin Harvey Michael John Munchhof Michael Thomenius Lawrence Alan Reiter | United States United States United States United States United States United States United States United States |